google_counter
background_img

University Hospital Erlangen

location_on Erlangen, Germany
9.1/10 from 51 Votes

Department of Nuclear Medicine (289959)

Torsten Kuwert

Prof. Dr. med.

Torsten Kuwert

Specialized in: nuclear medicine

About the department

The Department of Nuclear Medicine at the University Hospital Erlangen offers the full range of diagnostic and therapeutic services in its specialization. Of particular interest are PET/CT, SPECT/CT, as well as innovative therapeutic methods of nuclear medicine, such as peptide radioreceptor therapy for neuroendocrine tumors, radioembolization of liver tumors and treatment of prostate cancer with radioligands targeting a prostate specific membrane antigen (PSMA therapy). The highly qualified world-renowned doctors take care of the patients. The department is headed by Prof. Dr. med. Torsten Kuwert.

The department has a specialized outpatient clinic for the diagnostics and treatment of all benign and malignant thyroid diseases. The diagnostic capabilities include ultrasound examinations of various modifications (three modern high-resolution ultrasound machines), thyroid scintigraphy and SPECT/CT, which is rarely required. The tests to determine thyroid hormones and antibody levels are carried out in the in-house laboratory. Further laboratory tests are carried out in the central laboratory of the university hospital. The doctors of the outpatient clinic are experienced experts in the field of radioiodine therapy and always inform patients about the details of the course of therapy and the indications for it before its start. The clinical cases of patients with thyroid malignancies are considered at the interdisciplinary consultations, after which the optimal treatment tactics is selected.

The service range of the department includes:

  • Diagnostic options
    • PET, PET/CT and PET/MR
      • Brain tumors (gliomas)
      • Recurrent prostate cancer
      • Neuroendocrine tumors
      • Inflammatory processes
      • Diagnostics of myocardial condition
    • Scintigraphy and SPECT/CT
      • Endocrinology
        • Thyroid scintigraphy using sodium pertechnetate 99mTc or MIBI Tc-99m
        • Parathyroid scintigraphy
      • Gastroenterology and pulmonology
        • Perfusion lung scintigraphy
        • Salivary gland scintigraphy
        • Scintigraphy to assess the dynamics of gastric emptying
        • Scintigraphy in case of suspected Meckel's diverticulum
        • Search for the source of bleeding using Tc-99m-labeled red blood cells
        • Spleen scintigraphy
      • Oncology
        • Bone scintigraphy
        • Scintigraphy to determine the expression of somatostatin receptors using Tc-99m-Tectreotyd
        • I-123 MIBG scintigraphy
        • Scintigraphy to determine the expression of PSMA (prostate specific membrane antigen) with Tc-99m MIP1404
      • Cardiology
        • Myocardial perfusion scintigraphy
        • Myocardial viability assessment
        • Assessment of sympathetic innervation using I-123-MIBG
      • Nephrology and urology
        • Dynamic kidney scintigraphy using TER-MAG-3 (Tc-99m-MAG-3)
        • Static kidney scintigraphy (Tc-99m-DMSA)
      • Neurology
        • Perfusion brain scintigraphy
        • Diagnostics of Parkinson's disease using FP-CIT-SPECT (dopamine-amino transporter scintigraphy) and IBZM-SPECT (dopamine receptor-2 scintigraphy)
      • Orthopedics and traumatology
        • Bone scintigraphy
        • Diagnostics of inflammatory processes using granulocyte antibody scintigraphy
  • Therapy
    • Radioiodine therapy for benign and malignant thyroid diseases
    • Peptide radioreceptor therapy (PRRT) for neuroendocrine tumors
    • Lutetium-177-PSMA therapy for metastatic prostate cancer
    • Selective internal radiation therapy for primary malignant neoplasms of the liver and liver metastases
    • Xofigo® therapy (radium-223-dichloride) for the treatment of bone metastases in prostate cancer
    • Radiosynoviorthesis (RSO) in chronic inflammatory joint diseases
    • Zevalin therapy
  • Other diagnostic and therapeutic services

Curriculum vitae

Education

  • 1986 Master of Engineering, Rhine-Westphalian Technical Aachen University, Germany.

Professional Career

  • 1986 - 1992 Assistant, Institute of Microelectronics/Children with Food Allergies, Juelich, Germany.
  • 1992 - 1994 Associate Professor, Institute of Microelectronics/Children with Food Allergies, Juelich, Germany.
  • 1994 - 1997 Associate Professor, Department of Nuclear Medicine, University of Muenster, Germany.
  • 1997 Head and Professor, Department of Nuclear Medicine, Institute for Nuclear Medicine, Bad Oeynhausen, Germany.
  • Head of the Department of Nuclear Medicine at the University Hospital Erlangen.

Department of Nuclear Medicine.
University Hospital Erlangen:

Request more information now.
We will be happy to answer all your questions.


Certificates

Need Help?

Thank you!

We received your treatment application in the best Europe clinics. Our manager will contact you within the next 24 hours.